# Hatteras Venture Partners

Hatteras Venture Partners is a Venture Capital based in Durham, United States.

## Overview

- **Organization type:** Venture Capital
- **Headquarters:** Durham, United States
- **Region:** North America
- **Address:** Durham, NC, United States
- **Founded:** 2000
- **Assets under management:** Undisclosed
- **Website:** hatterasvp.com
- **LinkedIn:** https://www.linkedin.com/company/592114

## Regulatory record

- **CRD number:** 320715
- **SEC file number:** 802-75759
- **Registration status:** ACTIVE
- **Latest Form ADV filing:** 2026-03-31T05:00:00.000Z
- **Reports private funds:** Yes
- **Private funds reported:** 0
- **IAPD record:** https://adviserinfo.sec.gov/firm/summary/320715

## About

Hatteras Venture Partners is a venture capital firm focused on building transformational companies in human medicine. The firm invests broadly across biotech, medtech, and healthtech, partnering with founders from initial investment to liquidity. Based in the Research Triangle, Hatteras has over 25 years of experience and has built more than 100 companies.

## Sectors

- Biotech
- MedTech
- HealthTech

## People

- Clay Thorp — General Partner
- John Crumpler — General Partner

## Questions

### Who runs investment decisions at Hatteras Venture Partners?

Clay Thorp and John Crumpler serve as General Partners and guide the firm's investment strategy. A team of investment professionals with scientific and operational backgrounds supports sourcing and diligence. Specific portfolio management responsibilities are not publicly detailed.

### How does Hatteras Venture Partners source proprietary deal flow?

The firm draws heavily on its embedded position within the Research Triangle, leveraging relationships with Duke, UNC, and N.C. State. Proximity to academic technology transfer offices, regional incubators, and a deep bench of life-science repeat founders yields early looks at company formation before broader syndication processes begin.

### Does Hatteras Venture Partners participate in fund commitments or only direct deals?

Hatteras primarily makes direct equity investments in early-stage life-sciences companies. The firm occasionally co-invests alongside other venture syndicates but does not operate as a fund-of-funds or make passive LP commitments as a primary strategy.

### What investment stages does Hatteras Venture Partners typically target?

The firm focuses on seed and early-stage investments, often providing initial institutional capital for companies advancing preclinical or early clinical programs. It maintains reserves for follow-on participation in subsequent financing rounds for portfolio holdings.

### Which sectors does Hatteras Venture Partners explicitly avoid?

Hatteras concentrates on human health and has no disclosed activity in non-life-science verticals such as enterprise software, consumer internet, or climate technology. Within health, its portfolio spans therapeutics, devices, and healthcare services, but it has not stated explicit exclusions within those categories.

### How is Hatteras Venture Partners tied to the Research Triangle ecosystem?

The firm was founded and remains headquartered in Durham, North Carolina, adjacent to Duke University and the broader Triangle research corridor. Its investment team has historically included partners with academic and operational ties to the region, and the portfolio reflects a bias toward companies founded around intellectual property from area universities and research institutions.

## Related profiles

- [Hathway Investment Nepal](https://altss.com/profile/hathway-investment-nepal)
- [Hattington Investment Partners](https://altss.com/profile/hattington-investment-partners)

---

Last updated: 2026-07-11T01:53:44.000Z

Canonical page: https://altss.com/profile/hatteras-venture-partners

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology